GPNMB and Alzheimer disease: Follow-up analysis with an ELISA showed an increase in GPNMB ECF in the CSF of AD patients relative to non-AD controls, and the concentration of GPNMB ECF correlated with the spectrometry data from the same CSF sample [188].